-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Jk/kaD2gzn+RnTo8n5cYfFOkvpzKqZNwjatnOBSURvM5FvESUDmZX2w5E75X1bJu 3FcNNrjmNl8nhmUKAxZz4Q== 0000875320-08-000065.txt : 20080814 0000875320-08-000065.hdr.sgml : 20080814 20080814143618 ACCESSION NUMBER: 0000875320-08-000065 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080813 FILED AS OF DATE: 20080814 DATE AS OF CHANGE: 20080814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOGER JOSHUA S CENTRAL INDEX KEY: 0001197023 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 081017878 MAIL ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2008-08-13 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001197023 BOGER JOSHUA S C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139 1 1 0 0 President & CEO Common Stock 2008-08-13 4 M 0 12400 10.19 A 1107444 D Common Stock 2008-08-13 4 S 0 9400 28.97 D 1098044 D Common Stock 2008-08-13 4 S 0 3000 29.75 D 1095044 D Common Stock 12445 I 401(k) Common Stock 207500 I Shares in trust Stock Options 10.19 2008-08-13 4 M 0 12400 0 D 2008-09-16 Common Stock 12400 49978 D Transaction for sales of common stock made pursuant to Dr. Boger's company approved trading plan established under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $28.97 (range $28.54 to $29.53). Open market sales reported on this line occurred at a weighted average price of $29.75 (range $29.54 to $30.17). Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Shares held in trust for Dr. Boger's children. Dr. Boger disclaims beneficial ownership of such shares. Fully vested. Kenneth S. Boger, Attorney-In-Fact 2008-08-14 -----END PRIVACY-ENHANCED MESSAGE-----